Cargando…

Medication errors in a cohort of pediatric patients with acute lymphoblastic leukemia on remission induction therapy in a tertiary care hospital in Mexico

INTRODUCTION: Medication errors (MEs) are the main type of preventable adverse events in medical care, as well as safety indicators in the medication processes. Advances in the quality of care in pediatric acute lymphoblastic leukemia (ALL) have enabled to improve clinical outcomes. However, ME epid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez‐Cornejo, Edmundo, Morales‐Ríos, Olga, Juárez‐Villegas, Luis E., Islas Ortega, Erika J., Vázquez‐Estupiñán, Felipe, Garduño‐Espinosa, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792484/ https://www.ncbi.nlm.nih.gov/pubmed/31445000 http://dx.doi.org/10.1002/cam4.2438

Ejemplares similares

Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico
por: Vázquez-Cornejo, Edmundo, et al.
Publicado: (2022)

Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
por: Mejía-Aranguré, Eréndira, et al.
Publicado: (2022)

Resistance of t(17;19)‐acute lymphoblastic leukemia cell lines to multiagents in induction therapy
por: Watanabe, Atsushi, et al.
Publicado: (2019)

LINC00221 suppresses the malignancy of children acute lymphoblastic leukemia
por: Huang, Man, et al.
Publicado: (2020)

Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
por: Yoon, Jong Hyung, et al.
Publicado: (2009)

Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD
por: Brunvand, Mark W., et al.
Publicado: (2017)

Pharmacogenomic Markers of Glucocorticoid Response in The Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2018)

Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Jovanovska, Aleksandra, et al.
Publicado: (2019)

Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico
por: Morales-Ríos, Olga, et al.
Publicado: (2018)

Dysfunctional endothelial progenitor cells in patients with Hodgkin’s lymphoma in complete remission
por: Wiessman, Maya, et al.
Publicado: (2018)

Clinical characteristics and outcomes in a cohort of oncologic patients with COVID‐19 during the first year of the pandemic in Mexico
por: De‐la‐Rosa‐Martinez, Daniel, et al.
Publicado: (2022)

A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60‐year‐old acute myeloid leukemia patients with myelodysplasia syndrome features
por: Liu, Fengqi, et al.
Publicado: (2019)

Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis
por: Lee, Jae Han, et al.
Publicado: (2021)

The genomic landscape of teenage and young adult T‐cell acute lymphoblastic leukemia
por: Mansur, Marcela B., et al.
Publicado: (2021)

Ultrasonography‐driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine‐containing chemotherapy for the remission induction of acute myeloid leukemia
por: Pugliese, Novella, et al.
Publicado: (2017)

Immature Reticulocyte Fraction and Absolute Neutrophil Count as Predictor of Hemopoietic Recovery in Patients with Acute Lymphoblastic Leukemia on Remission Induction Chemotherapy
por: Rauf, Shan E., et al.
Publicado: (2016)

Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity
por: Abedi, Marjan, et al.
Publicado: (2020)

Nutritional Interventions in Pediatric Patients With Acute Lymphoblastic Leukemia: A Systematic Review
por: León, Alan Guzmán, et al.
Publicado: (2022)

Suppression of oral cancer by induction of cell cycle arrest and apoptosis using Juniperus communis extract
por: Lee, Ching-Chang, et al.
Publicado: (2020)

Spontaneous remission of acute lymphoblastic leukemia: A case report
por: Höres, Timm, et al.
Publicado: (2018)

Tisagenlecleucel: The First CAR on the Highway to Remission for Acute Lymphoblastic Leukemia
por: Freyer, Craig W.
Publicado: (2018)

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes
por: Swaika, Abhisek, et al.
Publicado: (2017)

Mutational profiling in acute lymphoblastic leukemia by RNA sequencing and chromosomal genomic array testing
por: Yeung, Cecilia, et al.
Publicado: (2021)

Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2019)

Successful outcome of disseminated Candida tropicalis osteomyelitis on remission induction for childhood Philadelphia chromosome–positive acute lymphoblastic leukaemia-case report
por: Xie, Lichun, et al.
Publicado: (2021)

A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia
por: Urayama, Kevin Y, et al.
Publicado: (2010)

Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL)
por: Padhye, Bhavna, et al.
Publicado: (2016)

Associations between early‐life and in utero infections and cytomegalovirus‐positive acute lymphoblastic leukemia in children
por: Gallant, Rachel E., et al.
Publicado: (2022)

Deep molecular responses for treatment‐free remission in chronic myeloid leukemia
por: Dulucq, Stéphanie, et al.
Publicado: (2016)

Relapse after Prolonged Remission in Philadelphia-Like Acute Lymphoblastic Leukemia
por: Shah, Gaurav, et al.
Publicado: (2019)

A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia
por: Xue, Yao, et al.
Publicado: (2019)

Integrated bioinformatics analysis of the crucial candidate genes and pathways associated with glucocorticoid resistance in acute lymphoblastic leukemia
por: Chen, Yanxin, et al.
Publicado: (2020)

Long‐term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98‐LEDGF rearrangement
por: Gallego Hernanz, Maria Pilar, et al.
Publicado: (2019)

Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia
por: Proc, Patrycja, et al.
Publicado: (2020)

Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B‐precursor acute lymphoblastic leukaemia
por: Huang, Qingsheng, et al.
Publicado: (2021)

Is hyperdiploidy a favorable cytogenetics in adults with B‐lymphoblastic leukemia?
por: Chen, Zhining, et al.
Publicado: (2019)

VAD chemotherapy as remission induction for multiple myeloma.
por: Anderson, H., et al.
Publicado: (1995)

CLIPPERS: Induction and maintenance of remission using hydroxychloroquine
por: Tan, Boon Loong, et al.
Publicado: (2015)

Induction of remission in diabetes by lowering blood glucose
por: Weir, Gordon C., et al.
Publicado: (2023)

Vedolizumab for induction and maintenance of remission in Crohn's disease
por: Hui, Samuel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gd6saoj54c8ihl8j4n1ijpsitt